{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:36:11Z","timestamp":1774294571544,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T00:00:00Z","timestamp":1481932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s13721-016-0143-4","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T14:16:46Z","timestamp":1481984206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploration of important sites of angiotensin II AT1 receptor of Pyrido [2, 3-d] pyrimidine analogues for structural modification using computational approach"],"prefix":"10.1007","volume":"6","author":[{"given":"M. C.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,17]]},"reference":[{"key":"143_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/ci0501286","volume":"46","author":"S Ajmani","year":"2006","unstructured":"Ajmani S, Jadhav K, Kulkarni SA (2006) Three-Dimensional QSAR using the k-Nearest Neighbor method and its interpretation. J Chem Inf Model 46:24\u201331","journal-title":"J Chem Inf Model"},{"key":"143_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/ci990070t","volume":"42","author":"K Baumann","year":"2002","unstructured":"Baumann K (2002) An alignment-independent versatile structure descriptor for QSAR and QSPR based on the distribution of molecular features. J Chem Inf Comput Sci 42:26\u201335","journal-title":"J Chem Inf Comput Sci"},{"key":"143_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0960-894X(01)81117-3","volume":"4","author":"P Buhlmayer","year":"1994","unstructured":"Buhlmayer P, Furet P, Criscione L, de Gasparo M, Whitebread S, Schmidlin T, Lattmann R, Wood J (1994) Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series. Bioorg Med Chem Lett 4:29\u201334","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"143_CR4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0022-3565(25)19981-3","volume":"252","author":"AT Chiu","year":"1990","unstructured":"Chiu AT, McCall DE, Price WA, Wong PC, Carini DJ, Duncia JV, Wexler RR, Yoo SE, Johnson AL, Timmermans PB (1990) Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 252(2):711\u2013718","journal-title":"J Pharmacol Exp Ther"},{"key":"143_CR5","volume-title":"Regression and linear models","author":"RB Darlington","year":"1990","unstructured":"Darlington RB (1990) Regression and linear models. McGraw-Hill, New York"},{"key":"143_CR6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","volume":"52","author":"M Gasparo de","year":"2000","unstructured":"de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415\u2013472","journal-title":"Pharmacol Rev"},{"key":"143_CR7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1021\/jm00030a013","volume":"37","author":"JW Ellingboe","year":"1994","unstructured":"Ellingboe JW, Antane M, Nguyen TT, Collini MD, Antane S, Bender R, Hartupee D, White V, McCallum J, Hyung PC, Russo A, Osler MB, Wojdan A, Dinish J, Ho DM, Bagli JF (1994) Pyrido[2,3-d] pyrimidine Angiotensin II Antagonists. J Med Chem 37:542\u2013550","journal-title":"J Med Chem"},{"issue":"Suppl. 3","key":"143_CR8","first-page":"S1","volume":"15","author":"CM Ferrario","year":"1990","unstructured":"Ferrario CM (1990) The renin-angiotensin system: importance in physiology and pathology. J Cardiovasc Pharmcol 15(Suppl. 3):S1\u2013S6","journal-title":"J Cardiovasc Pharmcol"},{"key":"143_CR9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1020869118689","volume":"16","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh A, Tropsha A (2002) Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J Comput Aided Mol Des 16:357\u2013369","journal-title":"J Comput Aided Mol Des"},{"key":"143_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/med.2610100203","volume":"10","author":"WJ Greenlee","year":"1990","unstructured":"Greenlee WJ (1990) Renin inhibitors. Med Res Reo 10:173\u2013236","journal-title":"Med Res Reo"},{"issue":"5\u20136","key":"143_CR11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<553::AID-JCC3>3.0.CO;2-T","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren TA (1996) Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94. J Comput Chem 17(5\u20136):553\u2013586","journal-title":"J Comput Chem"},{"key":"143_CR12","volume-title":"Exploring QSAR. Fundamentals and applications in chemistry and biology","author":"C Hansch","year":"1995","unstructured":"Hansch C, Leo A (1995) Exploring QSAR. Fundamentals and applications in chemistry and biology. American Chemical Society, Washington, DC"},{"issue":"1","key":"143_CR13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/scientificamerican0792-66","volume":"267","author":"JH Holland","year":"1992","unstructured":"Holland JH (1992) Genetic Algorithms. Sci Am 267(1):66\u201372","journal-title":"Sci Am"},{"issue":"Suppl. 1","key":"143_CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003495-199000391-00005","volume":"39","author":"CI Johnston","year":"1990","unstructured":"Johnston CI (1990) Biochemistry and pharmacology of the renin-angiotensin system. Drugs 39(Suppl. 1):21\u201331","journal-title":"Drugs"},{"key":"143_CR15","doi-asserted-by":"crossref","DOI":"10.1002\/9783527616824","volume-title":"QSAR: Hansch analysis and related approaches","author":"H Kubinyi","year":"1993","unstructured":"Kubinyi H (1993) QSAR: Hansch analysis and related approaches. VCH, New York"},{"key":"143_CR16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1359-6446(01)01990-0","volume":"6","author":"CJ Manly","year":"2001","unstructured":"Manly CJ, Louise-May S, Hammer JD (2001) The impact of informatics and computational chemistry on synthesis and screening. Drug Discov Today 6:1101\u20131110","journal-title":"Drug Discov Today"},{"issue":"25","key":"143_CR17","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1021\/jm00077a007","volume":"36","author":"UJ Ries","year":"1993","unstructured":"Ries UJ, Mihm G, Narr B, Hasselbach KM, Wittneben H, Entzeroth M, van Meel JC, Wienen W, Hauel NH (1993) 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships. J Med Chem 36(25):4040\u20134051","journal-title":"J Med Chem"},{"key":"143_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-6147(87)90013-7","volume":"8","author":"MB Vallotton","year":"1987","unstructured":"Vallotton MB (1987) The renin-angiotensin system. Trends Pharmacol Sci 8:69","journal-title":"Trends Pharmacol Sci"},{"key":"143_CR19","volume-title":"Molecular design suite","author":"VLife MDS 3.5","year":"2008","unstructured":"VLife MDS 3.5 (2008) Molecular design suite. Vlife Sciences Technologies Pvt. Ltd., Pune"},{"key":"143_CR20","first-page":"489","volume-title":"Pathophysiology of hypertension-regulatory mechanisms (handbook of hypertension, vol 8)","author":"B Waeber","year":"1986","unstructured":"Waeber B, Nussberger J, Brunner HR (1986) The renin-angiotensin system: role in experimental and human hypertension. In: Zanchetti A, Tarazi RC (eds) Pathophysiology of hypertension-regulatory mechanisms (handbook of hypertension, vol 8). Elsevier, Amsterdam, pp 489\u2013519"},{"key":"143_CR21","first-page":"2209","volume-title":"Hypertension pathophysiology, diagnosis and management","author":"B Waeber","year":"1990","unstructured":"Waeber B, Nussberger J, Brunner HR (1990) Angiotensin-converting-enzyme inhibitors in hypertension. In: Laragh JH, Brenner BM (eds) Hypertension pathophysiology, diagnosis and management. Raven Press, New York, pp 2209\u20132232"},{"issue":"3","key":"143_CR22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/HYPERTENSIONAHA.110.163402","volume":"57","author":"WB White","year":"2011","unstructured":"White WB, Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S (2011) Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension 57(3):413\u2013420","journal-title":"Hypertension"},{"key":"143_CR23","first-page":"195","volume-title":"Chemometric methods in molecular design","author":"S Wold","year":"1995","unstructured":"Wold S (1995) PLS for multivariate linear modeling. In: Van de Waterbeemd H (ed) Chemometric methods in molecular design. VCH, Weinheim, pp 195\u2013218"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13721-016-0143-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-016-0143-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-016-0143-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T18:16:18Z","timestamp":1749838578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13721-016-0143-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,17]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["143"],"URL":"https:\/\/doi.org\/10.1007\/s13721-016-0143-4","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"value":"2192-6662","type":"print"},{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,17]]},"article-number":"2"}}